Skip to main content
. 2022 Jun 9;12(6):e057159. doi: 10.1136/bmjopen-2021-057159

Table 3.

Systemic and local symptoms at baseline

Systemic symptoms All women (n=467) Breast implants in situ (n=388)
n % n %
Fatigue 409 88 340 88
Arthralgia 332 71 274 71
Morning stiffness 274 59 228 59
Myalgia 226 48 180 46
Cognitive impairment* 155 33 124 32
Peripheral neurological symptoms† 142 30 117 30
Lymphadenopathy 103 22 83 22
Sleeping problems 93 20 81 21
Dermatologic symptoms 91 19 76 20
Sicca complex 78 17 61 16
Night sweats 75 16 61 16
Dyspnoea 71 15 51 13
Headaches 66 14 56 14
Flu-like feeling, fever 49 10 38 10
Recurring infections/inflammation‡ 41 9 33 9
Alopecia 30 6 23 6
Itching 22 5 21 6
Local symptoms or changes
No local symptoms 122 31
Local symptoms 266 69
 Pain 189 49
 Changed size, form or consistence 87 22
 Capsular contracture 73 19
 Lymphadenopathy (axillary) 38 10
 Changed sensibility§ 19 4
 Local skin disorders 14 4
 Other¶ 86 22

*Cognitive impairment included memory problems, word finding problems and loss of concentration.

†Peripheral neurological symptoms included feelings of numbness, pins and needles, tingling.

‡Recurring infections or inflammation included recurrent urinary tract infections, upper respiratory infections and recurring tendonitis.

§Changed sensibility included loss of sensibility, burning sensation, or hyper sensibility.

¶Other symptoms included tight feeling around the chest, recurrent infections, heavy breasts or inability to wear a bra.